This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Pharmaking Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations by Wan Bae Kim in Eye Disease Treatment.
Introduction
Wan Bae Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of ophthalmology through his innovative research and development of pharmaceutical compositions aimed at preventing and treating eye diseases.
Latest Patents
Wan Bae Kim holds a patent for a composition designed to prevent or treat eye diseases, which contains S-allyl-L-cysteine as the active ingredient. This composition is particularly effective in inhibiting photo-oxidation and preventing the accumulation of A2E in retinal pigment epithelial cells. The invention addresses critical conditions such as age-related macular degeneration and degenerative retinal disorders.
Career Highlights
Throughout his career, Wan Bae Kim has worked with various organizations, including Pharmaking Co., Ltd. and Knu-industry Cooperation Foundation. His work has been instrumental in advancing the understanding and treatment of eye diseases.
Collaborations
Wan Bae Kim has collaborated with several professionals in his field, including Soon Bae Kim and Gwang Soon Kim. These collaborations have contributed to the development of innovative solutions in ophthalmology.
Conclusion
Wan Bae Kim's contributions to the treatment of eye diseases through his patented compositions highlight the importance of innovation in healthcare. His work continues to pave the way for advancements in the prevention and treatment of serious eye conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile